EFFICACY AND SAFETY OF EDARAVONE DEXBORNEOL FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE UNDERGOING ENDOVASCULAR THROMBECTOMY (TASTE-2): A MULTICENTER, DOUBLE-BLIND, PLACEBOCONTROLLED, RANDOMIZED CLINICAL TRIAL

被引:0
|
作者
Wang, C. [1 ]
Gu, H. [1 ]
Huo, X. [2 ]
Yuan, B. [1 ]
Li, S. [1 ]
Xu, J. [1 ]
Jiang, Y. [1 ]
Jing, J. [1 ]
Yao, X. [3 ]
Li, Z. [1 ,4 ]
Long, F. [5 ]
Ma, Z. [6 ]
Zhuang, X. [7 ]
Xu, L. [8 ]
Jin, Y. [9 ]
Huang, W. [10 ]
Zhang, Y. [11 ]
Wen, J. [12 ]
Wang, A. [13 ]
Pan, Y. [1 ]
Ye, W. [1 ]
Yu, W. [1 ]
Cheng, A. [1 ]
Wang, M. [1 ]
Dong, Q. [14 ]
Xu, A. [15 ]
Wang, N. [16 ]
Yang, Y. [17 ]
Meng, X. [1 ]
Liu, L. [1 ]
Zhao, X. [1 ]
Li, H. [1 ]
Miao, Z. [1 ]
Li, Z. [1 ,4 ]
Wang, Y. [18 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Ctr Neurol Dis, Cerebrovasc Dis Dept, Beijing, Peoples R China
[3] First Peoples Hosp Chen Zhou City, Dept Neurol, Chenzhou, Peoples R China
[4] Peoples Hosp Huazhou, Huazhou, Peoples R China
[5] Second Affliated Hosp Hainan Med Univ, Haikou, Hainan, Peoples R China
[6] Suzhou Hosp Anhui Med Univ, Suzhou, Peoples R China
[7] Liaocheng Peoples Hosp, Liaocheng, Shandong, Peoples R China
[8] Cent Hosp Jiamusi City, Jiamusi, Heilongjiang, Peoples R China
[9] Peoples Hosp Bozhou, Bozhou, Peoples R China
[10] Maoming Hosp Guangzhou Univ Chinese Med, Maoming, Peoples R China
[11] First Peoples Hosp Wenling, Wenling, Peoples R China
[12] First Peoples Hosp Changde City, Changde, Peoples R China
[13] China Natl Clin Res Ctr Neurol Dis, Dept Stat, Beijing, Peoples R China
[14] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China
[15] First Affiliated Hosp Jinan Univ, Guangzhou, Peoples R China
[16] First Affiliated Hosp Fujian Med Univ, Fuzhou, Peoples R China
[17] First Hosp Jilin Univ, Dept Neurol, Stroke Ctr, Changchun, Peoples R China
[18] Beijing Tiantan Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
O127 / #3
引用
收藏
页码:58 / 58
页数:1
相关论文
共 50 条
  • [1] Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke A Phase III, Randomized, Double-Blind, Comparative Trial
    Xu, Jie
    Wang, Anxin
    Meng, Xia
    Yalkun, Gulbahram
    Xu, Anding
    Gao, Zhiqiang
    Chen, Huisheng
    Ji, Yong
    Xu, Jun
    Geng, Deqin
    Zhu, Runxiu
    Liu, Bo
    Dong, Aiqin
    Mu, Hua
    Lu, Zhihong
    Li, Shuya
    Zheng, Huaguang
    Chen, Xia
    Wang, Yilong
    Zhao, Xingquan
    Wang, Yongjun
    STROKE, 2021, 52 (03) : 772 - 780
  • [2] Safety And Efficacy Of Edaravone Dexborneol Versus Edaravone Alone For The Treatment Of Acute Ischemic Stroke Patients With Hypertention: Analysis From Taste Trial
    Xu, Jie
    Wang, Yongjun
    HYPERTENSION, 2021, 78
  • [3] Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
    Wang, Chunjuan
    Gu, Hong-Qiu
    Dong, Qiang
    Xu, Anding
    Wang, Ning
    Yang, Yi
    Wang, Feng
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2024, 9 (06) : 730 - 737
  • [4] Combined Selective Endovascular Brain Hypothermia with Edaravone Dexborneol versus Edaravone Dexborneol Alone for Endovascular Treatment in Acute Ischemic Stroke (SHE): Protocol for a Multicenter, Single-Blind, Randomized Controlled Study
    Jiang, Xin
    Chen, Lizhang
    Wang, Jian
    Fang, Jinghuan
    Ma, Mengmeng
    Zhou, Muke
    Zheng, Hongbo
    Hu, Fayun
    Zhou, Dong
    He, Li
    CEREBROVASCULAR DISEASES, 2024,
  • [5] A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
    Sharma, Pawan
    Sinha, Manish
    Shukla, R.
    Garg, R. K.
    Verma, R.
    Singh, M. K.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2011, 14 (02) : 103 - 106
  • [6] Sublingual edaravone dexborneol for the treatment of acute ischemic stroke: the TASTE-SL randomized clinical trial (vol 81, pg 319, 2024)
    Fu, Y.
    Wang, A.
    Tang, R.
    JAMA NEUROLOGY, 2024, 81 (04) : 425 - 425
  • [7] Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial
    Yi Zhu
    Guangyun Zhang
    Jun Zhao
    Deshuai Li
    Xiaodong Yan
    Juanfang Liu
    Xuedong Liu
    Haibo Zhao
    Jielai Xia
    Xiao Zhang
    Zhengyi Li
    Baorong Zhang
    Zongcheng Guo
    Lianyuan Feng
    Zhaodong Zhang
    Fang Qu
    Gang Zhao
    Clinical Drug Investigation, 2013, 33 : 755 - 760
  • [8] Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial
    Zhu, Yi
    Zhang, Guangyun
    Zhao, Jun
    Li, Deshuai
    Yan, Xiaodong
    Liu, Juanfang
    Liu, Xuedong
    Zhao, Haibo
    Xia, Jielai
    Zhang, Xiao
    Li, Zhengyi
    Zhang, Baorong
    Guo, Zongcheng
    Feng, Lianyuan
    Zhang, Zhaodong
    Qu, Fang
    Zhao, Gang
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 755 - 760
  • [9] Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
    Xu, Jie
    Wang, Yilong
    Wang, Anxin
    Gao, Zhiqiang
    Gao, Xiaoping
    Chen, Huisheng
    Zhou, Junshan
    Zhao, Xingquan
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2019, 4 (03) : 109 - 114
  • [10] Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment A Phase 1/2 Randomized Clinical Trial
    Hernandez-Jimenez, Macarena
    Abad-Santos, Francisco
    Cotgreave, Ian
    Gallego, Jaime
    Jilma, Bernd
    Flores, Alan
    Jovin, Tudor G.
    Vivancos, Jose
    Hernandez-Perez, Maria
    Molina, Carlos A.
    Montaner, Joan
    Casariego, Joaquin
    Dalsgaard, Mads
    Liebeskind, David S.
    Cobo, Erik
    Castellanos, Mar
    Portela, Pere Cardona
    Masjuan, Jaime
    Moniche, Francisco
    Tembl, Jose Ignacio
    Izaga, Mikel Terceno
    Arenillas, Juan F.
    Callejas, Patricia
    Olivot, Jean Marc
    Calviere, Lionel
    Henon, Hilde
    Mazighi, Mikael
    Pineiro, David
    Pugliese, Marco
    Gonzalez, Victor M.
    Moro, Maria Angeles
    Garcia-Tornel, Alvaro
    Lizasoain, Ignacio
    Ribo, Marc
    JAMA NEUROLOGY, 2023, 80 (08) : 779 - 788